Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer
- PMID: 30876667
- DOI: 10.1016/j.surg.2019.01.025
Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer
Abstract
Background: Lymph node metastases from papillary thyroid cancer is believed to disseminate sequentially, first to the central neck and later to the lateral neck. Skip metastases of papillary thyroid cancer, however, are defined as lateral lymph node metastasis without central lymph node metastasis. The aim of this study was to investigate the risk factors for skip metastases and lateral lymph node metastasis of papillary thyroid cancer.
Methods: We reviewed 721 papillary thyroid cancer patients undergoing total thyroidectomy with central lymph node dissection and lateral lymph node dissection during 2013 to 2018. Multivariate logistic regression analysis was performed to identify clinicopathologic risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
Results: The rate of skip metastases was 7.4% (42 of 567 patients). Multivariate analysis showed that female sex and papillary thyroid microcarcinoma (≤ 1 cm) were independent risk factors for skip metastases, with odds ratios ([OR], 95% confidence interval [CI]) of 2.29 (1.02-5.16) and 2.84 (1.46-5.16), respectively. Intrathyroidal spread of papillary thyroid cancer and an increased number of central lymph nodes dissected were inversely associated with skip metastases with ORs (95% CI) of 0.13 (0.02-0.99) and 0.88 (0.83-0.94), respectively. In contrast, a greater tumor size, central lymph node metastasis, an increased number of central lymph nodes dissected, and an increased number of lateral lymph nodes dissected were associated with a lateral lymph node metastasis risk of papillary thyroid cancer, with ORs (95% CI) as follow: 1.67 (1.08-2.59), 3.07 (1.71-5.52), 1.25 (1.14-1.37), and 1.07 (1.04-1.10), respectively, by multivariate analysis.
Conclusion: Greater tumor size, central lymph node metastasis, and an increased number of both central lymph nodes and lateral lymph nodes dissected were predictors for lateral lymph node metastasis of papillary thyroid cancer. In addition, papillary thyroid microcarcinoma was an independent risk factor for skip metastases. A complete and comprehensive central compartment dissection may decrease the false-positive detection of skip metastases of papillary thyroid cancer.
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
-
A Diagnostic Dilemma: Skip Metastasis in Papillary Thyroid Cancer.Am Surg. 2020 Mar 1;86(3):245-249. Am Surg. 2020. PMID: 32223805
-
Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.Head Neck. 2015 Sep;37(9):1336-43. doi: 10.1002/hed.23747. Epub 2014 Oct 29. Head Neck. 2015. PMID: 24821456
-
Risk Factors for and Prediction Model of Skip Metastasis to Lateral Lymph Nodes in Papillary Thyroid Carcinoma.World J Surg. 2020 May;44(5):1498-1505. doi: 10.1007/s00268-019-05332-0. World J Surg. 2020. PMID: 31863139
-
Risk factors for contralateral central lymph node metastasis in unilateral cN0 papillary thyroid carcinoma: A meta-analysis.Int J Surg. 2018 Nov;59:90-98. doi: 10.1016/j.ijsu.2018.09.004. Epub 2018 Oct 17. Int J Surg. 2018. PMID: 30342280 Review.
-
Skip metastases to lateral cervical lymph nodes in differentiated thyroid cancer: a systematic review.BMC Surg. 2019 Apr 24;18(Suppl 1):112. doi: 10.1186/s12893-018-0435-y. BMC Surg. 2019. PMID: 31074393 Free PMC article.
Cited by
-
Integrated analysis of RNA-binding proteins in thyroid cancer.PLoS One. 2021 Mar 12;16(3):e0247836. doi: 10.1371/journal.pone.0247836. eCollection 2021. PLoS One. 2021. PMID: 33711033 Free PMC article.
-
The prognostic value of lymph node ratio for thyroid cancer: a meta-analysis.Front Oncol. 2024 Feb 7;14:1333094. doi: 10.3389/fonc.2024.1333094. eCollection 2024. Front Oncol. 2024. PMID: 38384804 Free PMC article.
-
PTC located in the upper pole is more prone to lateral lymph node metastasis and skip metastasis.World J Surg Oncol. 2020 Jul 28;18(1):188. doi: 10.1186/s12957-020-01965-x. World J Surg Oncol. 2020. PMID: 32723382 Free PMC article.
-
Prophylactic central lymph node dissection performed selectively with cN0 papillary thyroid carcinoma according to a risk-scoring model.Gland Surg. 2022 Feb;11(2):378-388. doi: 10.21037/gs-21-906. Gland Surg. 2022. PMID: 35284301 Free PMC article.
-
Relationship between postoperative nodal skip metastasis of mid-thoracic esophageal squamous cell carcinoma and patient prognosis and its value in guiding postoperative adjuvant treatment.Front Surg. 2023 Jan 9;9:1038731. doi: 10.3389/fsurg.2022.1038731. eCollection 2022. Front Surg. 2023. PMID: 36700007 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical